tiprankstipranks
Telomir Pharmaceuticals, Inc. (TELO)
:TELO
US Market

Telomir Pharmaceuticals, Inc. (TELO) Income Statement

Compare
56 Followers

Telomir Pharmaceuticals, Inc. Income Statement

Last quarter (Q4 2024), Telomir Pharmaceuticals, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Telomir Pharmaceuticals, Inc.'s net income was $-2.90M. See Telomir Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -3.94M$ 0.00$ 0.00
Operating Expenses
$ 11.87M$ 3.94M$ 854.15K$ 138.13K
Depreciation and Amortization
$ 0.00$ -7.49M$ 854.15K$ 138.13K
EBITDA
$ 0.00$ -11.43M$ -854.15K$ -138.13K
Operating Income
$ 0.00$ -3.94M$ -854.15K$ -138.13K
Other Income/Expenses
$ 0.00$ -9.13M$ 0.00$ 0.00
Pretax Income
$ -16.53M$ -13.07M$ -854.15K$ -138.13K
Net Income
$ -16.53M$ -13.07M$ -854.15K$ -138.13K
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -0.56$ -0.44$ -0.03$ 0.00
Diluted EPS
$ -0.56$ -0.44$ -0.03$ 0.00
Weighted Average Shares Outstanding
29.54M 29.61M 29.61M 29.61M
Weighted Average Shares Outstanding (Diluted)
29.54M 29.61M 29.61M 29.61M
Currency in USD

Telomir Pharmaceuticals, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis